Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: LaurietCecília Monteiro, William Alvin McElveen, Seema Datta et al.|Neurology|2023Cited by 104
Efficacy and safety of abobotulinumtoxinA in spastic lower limbJean‐Michel Graciès, A A Skoromets, Alberto Esquenazi et al.|Neurology|2017Cited by 96